Pneumococcal disease
Clinical trials for Pneumococcal disease explained in plain language.
Never miss a new study
Get alerted when new Pneumococcal disease trials appear
Sign up with your email to follow new studies for Pneumococcal disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new vaccine outsmart pneumococcal disease?
Vaccine Not yet recruitingThis trial tests a new pneumococcal vaccine, called PG4, in adults aged 18 to 49. Researchers compare three batches of PG4 to each other and to the current vaccine, Prevnar 20, to see if they produce similar immune responses and are equally safe. Participants receive one injectio…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Sep 02, 2026 00:00 UTC
-
Can a pneumonia vaccine protect the most vulnerable children?
Vaccine Not yet recruitingThis study tests whether a pneumococcal vaccine (Pneumosil) can produce a strong immune response in children aged 6-59 months who are hospitalised with severe acute malnutrition. Half the children will receive the pneumococcal vaccine, and the other half will receive a typhoid va…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase 4 • Sponsor: Nick Fancourt • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC